High Sustained Virologic Response (SVR) Among Genotype I Previous Non-Responders and Relapsers to Peginterferon/Ribavirin When Re-Treated with Boceprevir (BOC) Plus Peginterferon Alfa-2A/Ribavirin

被引：0
|
作者：
Flamm, Steven L.
Lawitz, Eric J.
Jacobson, Ira M.
Rubin, Raymond A.
Bourliere, Marc
Hezode, C.
Vierling, J.
Niederau, Claus
Sherman, Morris
Goteti, Venkata S.
Vilchez, Regis A.
Brass, Clifford A.
Albrecht, Janice K.
Poordad, Fred
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S145 / S145
页数：1
相关论文
共 50 条
  • [41] ADHERENCE TO ASSIGNED DOSING REGIMEN AND SUSTAINED VIROLOGIC RESPONSE AMONG HEPATITIS C GENOTYPE 1 TREATMENT-NAIVE AND PEG/RIBAVIRIN TREATMENT-FAILURES TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
    Gordon, S. C.
    Lawitz, E. J.
    Bacon, B. R.
    Sulkowski, M. S.
    Yoshida, E. M.
    Davis, M.
    Boparai, N.
    Sniukiene, V.
    Burroughs, M.
    Brass, C. A.
    Albrecht, J. K.
    Reddy, K. R.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S173 - S174
  • [42] FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN
    Vierling, J. M.
    Lawitz, E. J.
    Poordad, F.
    Sulkowski, M. S.
    Bourliere, M.
    Buti, M.
    Cooper, C.
    Galati, J. S.
    Albrecht, J. K.
    Boparai, N.
    Brass, C. A.
    Burroughs, M.
    Sniukiene, V.
    Bruno, S.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S197 - S197
  • [43] Adherence to Assigned Dosing Regimen and Sustained Virologic Response Among Hepatitis C Genotype 1 Treatment-NaiVE and PEG/Ribavirin Treatment-Failures Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin
    Gordon, Stuart C.
    Lawitz, Eric J.
    Bacon, Bruce R.
    Sulkowski, Mark
    Yoshida, Eric M.
    Davis, Mitchell N.
    Boparai, Navdeep
    Sniukiene, Vilma
    Burroughs, Margaret
    Brass, Clifford A.
    Albrecht, Janice K.
    Reddy, Rajender
    GASTROENTEROLOGY, 2011, 140 (05) : S944 - S944
  • [44] SUSTAINED VIROLOGIC RESPONSE (SVR) IN PRIOR PEGINTERFERON/RIBAVIRIN (PR) TREATMENT FAILURES AFTER RETREATMENT WITH BOCEPREVIR (BOC)-+-PR: THE PROVIDE STUDY INTERIM RESULTS
    Bronowicki, J. P.
    Davis, M.
    Flamm, S.
    Gordon, S.
    Lawitz, E.
    Yoshida, E.
    Galati, J.
    Luketic, V.
    McCone, J.
    Jabobson, I.
    Marcellin, P.
    Muir, A.
    Poordad, F.
    Pedicone, L. D.
    Deng, W.
    Treitel, M.
    Wahl, J.
    Vierling, J.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S6 - S6
  • [45] Timing and magnitude of ribavirin dose reduction (RBV DR) do not impact sustained virologic response (SVR) rates with boceprevir (BOC) plus peginterferon alfa-2b/ribavirin (P/RBV) in the Anemia Management Study in chronic HCV genotype 1 patients
    Poordad, Fred
    Lawitz, Eric
    Reddy, K. Rajender
    Afdhal, Nezam
    Hezode, Christophe
    Zeuzem, Stefan
    Lee, Samuel S.
    Calleja, Jose L.
    Brown, Robert S.
    Craxi, Antonio
    Wedemeyer, Heiner
    Bacon, Bruce R.
    Flamm, Steven L.
    Deng, Weiping
    Koury, Kenneth J.
    Pedicone, Lisa
    Dutko, Frank
    Burroughs, Margaret
    Alves, Katia
    Wahl, Janice
    Brass, Clifford
    Albrecht, Janice K.
    Sulkowski, Mark S.
    HEPATOLOGY, 2012, 56 : 269A - 270A
  • [46] RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1
    Manns, M. P.
    Poordad, F.
    Bacon, B. R.
    Bruno, S.
    Esteban, R.
    Silva, M.
    Buti, M.
    Burroughs, M.
    Sniukiene, V.
    Boparai, N.
    Brass, C. A.
    Albrecht, J. K.
    Bronowicki, J. -P.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S182 - S183
  • [47] High response rates with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in Japanese non-responders or relapsers to conventional interferon
    Izumi, N.
    Iino, S.
    Okuno, T.
    Omata, M.
    Kiyosawa, K.
    Kumada, H.
    Hayashi, N.
    Yamada, G.
    Sakai, T.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S216 - S216
  • [48] SUSTAINED VIROLOGIC RESPONSE IS ASSOCIATED WITH WORSE QOL DURING AND IMPROVED QOL AFTER TREATMENT WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN
    von Wagnerl, Michael
    Hofmann, W. Peter
    Teuber, Gerlinde
    Berg, Thomas
    Goeser, Tobias
    Spengler, Ulrich
    Hinrichsen, Holger
    Weidenbach, Hans
    Gerken, Guido
    Manns, Michael P.
    Buggisch, Peter
    Herrmann, Eva
    HEPATOLOGY, 2008, 48 (04) : 886A - 887A
  • [49] Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response
    Howell, CD
    Jeffers, LS
    Cassidy, W
    Reddy, KR
    Hu, S
    Lee, JS
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (06) : 371 - 376
  • [50] Response to high ribavirin dose in combination with peg-INF alfa-2a for treatment of HCV genotype 1 previous non-responders
    Hornfeldt, Erika
    Stahle, Lars
    Schvarcz, Robert
    Weiland, Ola R.
    Carlsson, Tony
    Hollander, Anna
    Lindahl, Karin
    HEPATOLOGY, 2007, 46 (04) : 350A - 350A
12345